[
1. Vogelmeier CF, Criner GJ, Martinez FJ, Anzueto A, Barnes PJ, Bourbeau J, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease 2017 report. GOLD executive summary. Am J Respir Crit Care Med. 2017;195(5):557-82. DOI: 10.1164/rccm.201701-0218PP10.1164/rccm.201701-0218PP28128970
]Search in Google Scholar
[
2. Lopez AD, Murray CC. The global burden of disease, 1990-2020. Nat Med. 1998;4(11):1241-3. DOI: 10.1038/321810.1038/32189809543
]Search in Google Scholar
[
3. Mannino DM, Higuchi K, Yu TC, Zhou H, Li Y, Tian H, et al. Economic burden of COPD in the presence of comorbidities. Chest. 2015;148(1):138-50. DOI: 10.1378/chest.14-243410.1378/chest.14-2434449387025675282
]Search in Google Scholar
[
4. Beijers RJ, Gosker HR, Schols AM. Resveratrol for patients with chronic obstructive pulmonary disease: hype or hope? Curr Opin Clin Nutr Metab Care. 2018;21(2):138-44. DOI: 10.1097/MCO.000000000000044410.1097/MCO.0000000000000444581123329200030
]Search in Google Scholar
[
5. Gangemi S, Casciaro M, Trapani G, Quartuccio S, Navarra M, Pioggia G, et al. Association between HMGB1 and COPD: a systematic review. Mediat Inflamm 2015;21:164913. DOI: 10.1155/2015/16491310.1155/2015/164913469877826798204
]Search in Google Scholar
[
6. Patel AR, Singh S, Khawaja I. Global initiative for chronic obstructive lung disease: the changes made. Cureus. 2019;11(6):e4985. DOI: 10.7759/cureus.498510.7759/cureus.4985670190031453045
]Search in Google Scholar
[
7. Konietzke P, Jobst B, Wagner WL, Jarosch I, Graber R, Kenn K, et al. Similarities in the computed tomography appearance in α1-antitrypsin deficiency and smoking-related chronic obstructive pulmonary disease in a smoking collective. Respiration. 2018;96(3):231-39. DOI: 10.1159/00048917710.1159/00048917729940576
]Search in Google Scholar
[
8. Nie XH, Jiang C, Li XM. Effect of smoking on pulmonary function of male patients with chronic obstructive pulmonary disease and their correlation. West China Med J. 2017;32:852-56.
]Search in Google Scholar
[
9. Guiedem E, Ikomey GM, Nkenfou C, Walter PY, Mesembe M, et al. Chronic obstructive pulmonary disease (COPD): neutrophils, macrophages and lymphocytes in patients with anterior tuberculosis compared to tobacco related COPD. BMC Res Notes. 2018;11(1):192. DOI: 10.1186/s13104-018-3309-610.1186/s13104-018-3309-6586976429580274
]Search in Google Scholar
[
10. Lin FH, Zhang, HTan CM. The inflammatory response of elastin peptides in chronic obstructive pulmonary disease. Zhonghua Jie He He Hu Xi Za Zhi. 2018;41(6):496-98.
]Search in Google Scholar
[
11. Ignatova GL, Antonov VN. Impact of vaccination on the course of bronchial and systemic inflammation in patients with COPD and CHD. Terapevt Arkh. 2017;89(3):29-33. DOI: 10.17116/terarkh201789329-3310.17116/terarkh201789329-3328378726
]Search in Google Scholar
[
12. Cheng Y, Wang D, Wang B, Li H, Xiong J, Xu S, et al. HMGB1 translocation and release mediate cigarette smoke-induced pulmonary inflammation in mice through a TLR4/MyD88-dependent signaling pathway. Mol Biol Cell. 2017;28(1):201-09. DOI: 10.1091/mbc. e16-02-012610.1091/mbc.e16-02-0126
]Search in Google Scholar
[
13. Yates KP, Deppe R, Comerford M, Masuoka H, Cummings OW, Tonascia J, et al. Serum high mobility group box 1 protein levels are not associated with either histological severity or treatment response in children and adults with nonalcoholic fatty liver disease. Plos One. 2017;12(11):e0185813. DOI: 10.1371/journal. pone.018581310.1371/journal.pone.0185813
]Search in Google Scholar
[
14. Zhang XF, Qin Q, Geng WY, Jiang CW, Liu Y, Liu XL, et al. Electroacupuncture reduces hypothalamic and medullary expression of orexins and their receptors in a rat model of chronic obstructive pulmonary disease. Acupunct Med. 2018;36(5):312-18. DOI: 10.1136/acupmed-2017-01139110.1136/acupmed-2017-01139129669795
]Search in Google Scholar
[
15. Abolhalaj M, Askmyr D, Sakellariou CA, Lundberg K, Greiff L, Lindstedt M. Profiling dendritic cell subsets in head and neck squamous cell tonsillar cancer and benign tonsils. Sci Rep 2018;8(1):8030. DOI: 10.1038/s41598-018-26193-y10.1038/s41598-018-26193-y596644229795118
]Search in Google Scholar
[
16. Jiang YQ, Wu HY and Wen YQ. Detection and clinical significance of pathogen distribution and immune function in patients with AECOPD. J Parasit Biol. 2019;14:213-16.
]Search in Google Scholar
[
17. Huțanu A, Georgescu AM, Andrejkovits AV, Au W, Dobreanu M. Insights into Innate Immune Response Against SARS-CoV-2 Infection. Rev Romana Med Lab. 2021;29(3):255-69. DOI:10.2478/rrlm-2021-0022 DOI: 10.2478/rrlm-2021-002210.2478/rrlm-2021-0022
]Search in Google Scholar
[
18. Wechsler ME. Current and emerging biologic therapies for asthma and COPD. Respir Care. 2018;63(6):699-707. DOI: 10.4187/respcare.0632210.4187/respcare.0632229794205
]Search in Google Scholar
[
19. Xiong Y, Gao S, Luo G, Cheng G, Huang W, Jiang R, et al. Increased circulating autoantibodies levels of IgG, IgA, IgM against cytokeratin 18 and cytokeratin 19 in chronic obstructive pulmonary disease. Arch Med Res. 2017;48(1):79-87. DOI: 10.1016/j.arcmed.2017.01.00710.1016/j.arcmed.2017.01.00728577873
]Search in Google Scholar
